Purpose:
Glaucoma
INTRAOCULAR PRESSURE, GLAUCOMA
This work was presented in part at the American Glaucoma Society (AGS) 2021 Virtual Congress, March 4–7, 2021.To evaluate the time course of biodegradation of an intracameral, biodegradable, sustained-release bimatoprost implant that lowers intraocular pressure without the need for daily eye drops.